Cargando…

Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer

Development of neuroendocrine prostate cancer (NEPC) is emerging as a major problem in clinical management of advanced prostate cancer (PCa). As increasingly potent androgen receptor (AR)‐targeting antiandrogens are more widely used, PCa transdifferentiation into AR‐independent NEPC as a mechanism o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Stephen Yiu Chuen, Ettinger, Susan L., Lin, Dong, Xue, Hui, Ci, Xinpei, Nabavi, Noushin, Bell, Robert H., Mo, Fan, Gout, Peter W., Fleshner, Neil E., Gleave, Martin E., Collins, Colin C., Wang, Yuzhuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051138/ https://www.ncbi.nlm.nih.gov/pubmed/29905005 http://dx.doi.org/10.1002/cam4.1587

Ejemplares similares

Aneustat (OMN54) has aerobic glycolysis‐inhibitory activity and also immunomodulatory activity as indicated by a first‐generation PDX prostate cancer model
por: Qu, Sifeng, et al.
Publicado: (2018)

Metabolic heterogeneity signature of primary treatment-naïve prostate cancer
por: Lin, Dong, et al.
Publicado: (2017)

Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?
por: Choi, Stephen Yiu Chuen, et al.
Publicado: (2013)

Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development
por: Ci, Xinpei, et al.
Publicado: (2020)

Pre-clinical Models for Malignant Mesothelioma Research: From Chemical-Induced to Patient-Derived Cancer Xenografts
por: Nabavi, Noushin, et al.
Publicado: (2018)

Immune phenotypes of prostate cancer cells: Evidence of epithelial immune cell-like transition?
por: Lin, Dong, et al.
Publicado: (2016)

Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
por: Lin, Dong, et al.
Publicado: (2014)

Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma
por: Long, Yaping, et al.
Publicado: (2018)

The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications
por: Ramnarine, Varune Rohan, et al.
Publicado: (2018)

Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer
por: Qu, Sifeng, et al.
Publicado: (2018)

Genomic alterations in neuroendocrine prostate cancer: A systematic review and meta‐analysis
por: Chen, Junru, et al.
Publicado: (2023)

Hypoxia-induced PTTG3P contributes to colorectal cancer glycolysis and M2 phenotype of macrophage
por: Wang, Yue, et al.
Publicado: (2021)

Switching off malignant mesothelioma: exploiting the hypoxic microenvironment
por: Nabavi, Noushin, et al.
Publicado: (2016)

GATA2 as a potential metastasis-driving gene in prostate cancer
por: Chiang, Yan Ting, et al.
Publicado: (2014)

Potential Therapies for Infectious Diseases Based on Targeting Immune Evasion Mechanisms That Pathogens Have in Common With Cancer Cells
por: Wong, Jodi, et al.
Publicado: (2019)

The evolutionarily conserved long non‐coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms
por: Mather, Rebecca L., et al.
Publicado: (2021)

Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy
por: Chen, Hai‐Long, et al.
Publicado: (2018)

ZRSR2 overexpression is a frequent and early event in castration-resistant prostate cancer development
por: He, Haiqing, et al.
Publicado: (2021)

Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis
por: Amrutkar, Manoj, et al.
Publicado: (2023)

The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis
por: Iris Luk, Sze Ue, et al.
Publicado: (2014)

Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021)

Inhibition of Hypothalamic MCT4 and MCT1–MCT4 Expressions Affects Food Intake and Alters Orexigenic and Anorexigenic Neuropeptide Expressions
por: Elizondo-Vega, Roberto, et al.
Publicado: (2019)

Circ_0000235 targets MCT4 to promote glycolysis and progression of bladder cancer by sponging miR-330-5p
por: Zhong, Jianye, et al.
Publicado: (2023)

Oxaloacetate induces apoptosis in HepG2 cells via inhibition of glycolysis
por: Kuang, Ye, et al.
Publicado: (2018)

Autoregulation of H(+)/lactate efflux prevents monocarboxylate transport (MCT) inhibitors from reducing glycolytic lactic acid production
por: Blaszczak, Wiktoria, et al.
Publicado: (2022)

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
por: Wong, Chung, et al.
Publicado: (2012)

Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine‐non‐neuroendocrine neoplasm
por: Zhang, Panpan, et al.
Publicado: (2021)

METTL3 expression is associated with glycolysis metabolism and sensitivity to glycolytic stress in hepatocellular carcinoma
por: Lin, Ye, et al.
Publicado: (2020)

Silencing circSLAMF6 represses cell glycolysis, migration, and invasion by regulating the miR-204-5p/MYH9 axis in gastric cancer under hypoxia
por: Fang, Xinhui, et al.
Publicado: (2020)

Insights Into the Mechanism of MCT8 Oligomerization
por: Groeneweg, Stefan, et al.
Publicado: (2020)

Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells
por: Fan, Qing, et al.
Publicado: (2018)

Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer
por: Yan, Peng, et al.
Publicado: (2021)

Inhibition of lactate transport by MCT-1 blockade improves chimeric antigen receptor T-cell therapy against B-cell malignancies
por: Lopez, Ernesto, et al.
Publicado: (2023)

Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells
por: Kershaw, Stephen, et al.
Publicado: (2015)

Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis
por: Sheng, Gaohong, et al.
Publicado: (2023)

LncRNA LINC00857 regulates the progression and glycolysis in ovarian cancer by modulating the Hippo signaling pathway
por: Lin, Xueke, et al.
Publicado: (2020)

Critical Velocity, Maximal Lactate Steady State, and Muscle MCT1 and MCT4 after Exhaustive Running in Mice
por: Orsi, Juan B., et al.
Publicado: (2023)

Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4
por: Li, Yinan, et al.
Publicado: (2017)

Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP-mediated tumor growth and metastasis
por: Nokin, Marie-Julie, et al.
Publicado: (2016)

miR‐148b inhibits glycolysis in gastric cancer through targeting SLC2A1
por: Ding, Xiangfu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1pkhnmtsoge91ucbkg8squu31f